ghk cu iniekcja GHK-CU Peptyd NL-GHK-Cu™ (TETRAPEPTYD + CU)

While preclinical data is promising, its important to recognize that neither peptide is FDA-approved for human therapeutic use, and most evidence is derived from animal or laboratory studies

A decrease in SCFA-producing bacteria, especially butyrate producers like Faecalibacterium and Roseburia from the Firmicutes phylum , along with certain Bacteroides species, has been observed in ME/CFS patients [10, 25, 28]

the cortisol, cerebral-blood-flow and electrolyte mechanism

Benefits include: Accurate dosing Ease of use Reduced discomfort Improved consistency DOSAGE RECOMMENDATIONS Use strictly according to manufacturer specifications